Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers

Abstract Hospital healthcare workers (HCWs) are at increased risk of contracting COVID-19 infection. We aimed to determine the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in HCWs in Ireland. Two tertiary referral hospitals in Irish cities with diverging community incidence and seroprevalence were identified; COVID-19 had been diagnosed in 10.2% and 1.8% of staff respectively by the time of the study (October 2020). All staff of both hospitals (N = 9038) were invited to participate in an online questionnaire and blood sampling for SARS-CoV-2 antibody testing. Frequencies and percentages for positive SARS-CoV-2 antibody were calculated and adjusted relative risks (aRR) for participant characteristics were calculated using multivariable regression analysis. In total, 5788 HCWs participated (64% response rate). Seroprevalence of antibodies to SARS-CoV-2 was 15% and 4.1% in hospitals 1 and 2, respectively. Thirty-nine percent of infections were previously undiagnosed. Risk for seropositivity was higher for healthcare assistants (aRR 2.0, 95% confidence interval (CI) 1.4–3.0), nurses (aRR: 1.6, 95% CI 1.1–2.2), daily exposure to patients with COVID-19 (aRR: 1.6, 95% CI 1.2–2.1), age 18–29 years (aRR: 1.4, 95% CI 1.1–1.9), living with other HCWs (aRR: 1.3, 95% CI 1.1–1.5), Asian background (aRR: 1.3, 95% CI 1.0–1.6) and male sex (aRR: 1.2, 95% CI 1.0–1.4). The HCW seroprevalence was six times higher than community seroprevalence. Risk was higher for those with close patient contact. The proportion of undiagnosed infections call for robust infection control guidance, easy access to testing and consideration of screening in asymptomatic HCWs. With emerging evidence of reduction in transmission from vaccinated individuals, the authors strongly endorse rapid vaccination of all HCWs.

[1]  G. Koh Faculty Opinions recommendation of Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine. , 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[2]  S. Bhartiya,et al.  Seroprevalence of Antibodies Against SARS-CoV-2 Among Health Care Workers in Mumbai, India , 2020, Asia-Pacific journal of public health.

[3]  K. Khunti,et al.  Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff , 2020, Journal of public health.

[4]  Eric A. Meyerowitz,et al.  Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health. , 2020, JAMA.

[5]  J. Moon,et al.  Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply , 2020, The Lancet.

[6]  C. Fraenkel,et al.  Covid-19: risks to healthcare workers and their families , 2020, BMJ.

[7]  C. Fischbacher,et al.  Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study , 2020, BMJ.

[8]  P. Galanis,et al.  Seroprevalence of SARS-CoV-2 antibodies and associated factors in health care workers: a systematic review and meta-analysis , 2020, medRxiv.

[9]  H. Tegel,et al.  SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden , 2020, Nature Communications.

[10]  H. Htun,et al.  Asymptomatic health-care worker screening during the COVID-19 pandemic , 2020, The Lancet.

[11]  J. Deeks,et al.  Testing for SARS-CoV-2 antibodies , 2020, BMJ.

[12]  Jens K. Boldsen,et al.  SARS-CoV-2 seroprevalence survey among 18,000 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region , 2020, medRxiv.

[13]  F. Fitzpatrick,et al.  The role of healthcare staff COVID-19 screening in infection prevention & control , 2020, Journal of Infection.

[14]  A. Hatzakis,et al.  Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19 , 2020, medRxiv.

[15]  A. Rodger,et al.  Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England , 2020, Journal of Infection.

[16]  P. Vermeersch,et al.  Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. , 2020, JAMA.

[17]  Susan Michie,et al.  SARS-CoV-2 virus and antibodies in front-line Health Care Workers in an acute hospital in London: preliminary results from a longitudinal study , 2020, medRxiv.

[18]  A. Kribben,et al.  SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients , 2020, Journal of Clinical Virology.

[19]  William L. Hamilton,et al.  Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission , 2020, medRxiv.

[20]  Anne M Johnson,et al.  Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data. , 2020, Wellcome open research.

[21]  J. Hecht,et al.  Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital , 2020, Nature Communications.

[22]  Chuan Qin,et al.  Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China , 2020, JAMA network open.